Danaher claims victory for Summit’s Integrated DNA in $2 bln deal

Danaher Corp, Integrated DNA, Summit Partners, private equity, healthcare, biotechnology, merger, M&A
Photo courtesy of alexeynovikov/iStock/GettyImages
Danaher Corp on March 9 surfaced as the winning bidder for the highly sought after Integrated DNA Technologies. Terms weren’t disclosed, but the deal was valued at about $2 billion, Buyouts has learned. Danaher’s agreement for Integrated DNA, a  genomics-focused life-sciences ...

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.